You may qualify if you: Have a BMI of 30 or higher Have a BMI of 27 or higher with weight-related health conditions Your provider will review your medical history, lifestyle, and goals to determine if treatment is appropriate for you
Mol Metab 46:101102 Patoulias D, Popovic DS, Stoian AP, Janez A, Sahebkar A, Rizzo M (2023) Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: a systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials
The main differences across comparison categories are: Mechanism of Action: advantage goes to neither (tie)
Green flags include discussions referencing peer-reviewed studies, acknowledgment of individual variation, and emphasis on provider involvement
Rybelsus, another semaglutide, is also taken orally, once a day
High-fat diet induces apoptosis of hypothalamic neurons